On 16 October 2023, at the 33rd Alzheimer Europe Conference, a new report on "Advancing Diverse, Equitable and Inclusive Research in Alzheimer’s Disease Clinical Trials " was launched by Roche. For this report, Roche, in collaboration with patient organisations and experts in Diversity, Equity, and Inclusion (DE&I), examined the pressing need and challenges in achieving greater DE&I in Alzheimer's Disease (AD) clinical trials. The result is a comprehensive report outlining aspirations for DE&I in AD research and the essential steps necessary to reach those goals. Dianne Gove, Director for Public Involvement and Ethics at Alzheimer Europe, contributed to this report. You can download the report, here:
https://www.ieepo.com/en/useful-resources/learn-library.html?resource=4a7a65400abd
